Trends in Immunology
Volume 25, Issue 9, September 2004, Pages 489-495
Journal home page for Trends in Immunology

Platelets: signaling cells in the immune continuum

https://doi.org/10.1016/j.it.2004.07.003Get rights and content

Platelets have intricate signaling mechanisms and participate in a breadth of cellular interactions. This diversity is frequently unrecognized. In addition to being the chief cellular effectors of haemostasis, platelets are innate inflammatory cells that have previously unrecognized molecular pathways and synthetic capacities, which can link innate and adaptive responses in the immune continuum. Characterization of these features and parallel in vivo observations identify new sentinel, surveillance and information-transfer functions. Recent observations indicate that platelets have key roles in adaptive responses to microbial and antigen challenge, in addition to their well known acute defensive activities in tissue injury, and suggest that these mechanisms can be dysregulated in disease. Ongoing characterization of the platelet transcriptome, secretome and proteome also suggest that additional functions of platelets relevant to innate and adaptive immunity remain to be discovered. This Review is the third in a series on interactions between haemostasis and inflammation.

Section snippets

Platelets are rapidly targeted to sites of injury and infection

Because of their rapid accumulation and functional repertoire, platelets can have early roles in surveillance and information transfer similar to those accomplished by mast cells, macrophages and dendritic cells (DCs), which are pre-stationed in tissues to detect microbial invasion and wounding and provide advanced molecular intelligence and directives for subsequent responses [8]. Platelets undergo rapid homotypic aggregation in the blood (Figure 1) and adhesion to exposed subendothelial

The platelet secretome: activated platelets release inflammatory and immune-modulating factors

Activated platelets release factors of several classes that act as signals for target cells, including cells of the innate and adaptive immune systems (Table 1) 3, 4, 12, 13, 14, 15, 16, 17. Many secreted platelet factors are proteins and polypeptides that are stored in processed or precursor forms and can be rapidly released 12, 13, 14, 15, whereas others are the products of synthetic pathways that are rapidly triggered when platelets themselves receive activating signals (see later). The

Close encounters: platelet surface factors mediate intercellular signaling

Platelets not only secrete chemokines and other factors but also use signaling molecules anchored on the plasma membrane to mediate cell–cell adhesion and activate target cells (Figure 2). This provides a mechanism for spatially localized information transfer that is even more precise than paracrine secretion [6]. P-selectin, which is preformed and translocated from α granules to the surfaces of activated platelets, mediates adhesion to PMNs and monocytes by binding to a ligand on their plasma

Newly recognized synthetic capacities of activated platelets

Activated platelets rapidly produce thromboxane A2 (TXA2) (Table 1), a prothrombotic eicosanoid, from arachidonic acid in an enzymatic reaction catalyzed by constitutive cyclooxygenase-1 (COX-1). This pathway is a major therapeutic target in atherosclerotic vascular diseases [36]. Adherent platelets also synthesize PAF and use it to trigger local activation and adhesion of target leukocytes [6] (Figure 2). These examples illustrate the well known ability of activated platelets to synthesize

Cell–cell interactions involving platelets

The previous sections document that activated platelets release preformed mediators, display on their surfaces key members of ligand pairs, and synthesize new factors of several biochemical classes that can initiate, amplify or modify the immune continuum 7, 8 at multiple checkpoints and subserve defensive and surveillance functions. Cell–cell interactions involving platelets thus have the potential to exert crucial influences on inflammatory and immune outcomes. Platelet–platelet aggregation (

Platelet–DC interactions: information transfer to command and control adaptive immune cells

DCs link innate defensive responses and adaptive immunity 51, 56, 57. CD40L and IL-1β, which are displayed and released by platelets (see earlier), are among the most important endogenous ‘danger signals’ for DCs, and it has been suggested that platelets are early effectors of DC activation in tissue injury [57]. Murine platelets stimulated with thrombin induce in vitro activation and maturation of primary mouse bone marrow DCs by a mechanism dependent on platelet CD40L [31], consistent with

Platelets contribute to delayed hypersensitivity and adaptive immunity in vivo

Animal models support modulation of T-cell-mediated immune responses by platelets, including delayed-type hypersensitivity, contact sensitivity and adaptive immune responses to infection. As previously outlined, intravascular activated platelets reconstitute lymphocyte homing and responses to cutaneous antigen presentation in L-selectin-deficient mice, indicating crucial influences on lymphocyte trafficking and immunological memory in this model [28]. Circulating platelets also contribute

Concluding remarks

It is clear that platelets have signaling mechanisms and participate in cell–cell interactions that extend far beyond their traditional roles in haemostasis. Studies outlined in this Review indicate that these activities include interactions with key cells in the continuum of innate and adaptive immunity and that platelets might provide crucial signals in complex adaptive immune responses, establishing previously unrecognized sentinel and regulatory roles in tissue damage and infection.

Acknowledgements

We thank Thomas M. McIntyre and Stephan Lindemann for their collaboration, contributions, and insight into topics addressed in this review. We also thank many other collaborators and the fellows and students in our laboratories for their contributions, our technical staff for support of work cited, and our administrative staff. Diana Lim drafted the artwork and Michele Czerwinski and Mary Madsen prepared the manuscript. We also acknowledge the contributions of funding agencies that have

References (70)

  • A.S. Weyrich

    The evolving role of platelets in inflammation

    J. Thromb. Haemost.

    (2003)
  • M.R. Elstad

    The interaction of leukocytes with platelets in blood coagulation

    Curr. Opin. Hematol.

    (1995)
  • C. Herd et al.

    Do platelets have a role as inflammatory cells?

  • M.H. Klinger

    Inflammation

  • M. Yeaman et al.

    Antimicrobial host defense

  • T.M. McIntyre

    Cell–cell interactions: leukocyte–endothelial interactions

    Curr. Opin. Hematol.

    (2003)
  • R. Medzhitov et al.

    Innate immunity: the virtues of a nonclonal system of recognition

    Cell

    (1997)
  • C. Nathan

    Points of control in inflammation

    Nature

    (2002)
  • A.C. Issekutz

    Role of neutrophils in the deposition of platelets during acute inflammation

    Lab. Invest.

    (1983)
  • S.M. Prescott

    Platelet-activating factor and related lipid mediators

    Annu. Rev. Biochem.

    (2000)
  • G.P. Geba

    Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity

    J. Immunol.

    (1996)
  • E. Brandt

    Platelet-derived CXC chemokines: old players in new games

    Immunol. Rev.

    (2000)
  • F. Boehlen et al.

    Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?

    Transfus. Med.

    (2001)
  • P. Romagnani

    CXC chemokines: the regulatory link between inflammation and angiogenesis

    Trends Immunol.

    (2004)
  • J. Krijgsveld

    Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines

    J. Biol. Chem.

    (2000)
  • B.I. Schenk

    Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration

    J. Immunol.

    (2002)
  • A. Rouhiainen

    Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation

    Thromb. Haemost.

    (2000)
  • G. de Gaetano

    Recent advances in platelet-polymorphonuclear leukocyte interaction

    Haemostasis

    (1999)
  • M.J. Peters

    Circulating platelet–neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing

    Br. J. Haematol.

    (1999)
  • F. Sallusto

    Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses

    Immunol. Today

    (1998)
  • Y. Kameyoshi

    Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils

    J. Exp. Med.

    (1992)
  • A.S. Weyrich

    Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. Signal integration and NF-κB translocation

    J. Clin. Invest.

    (1995)
  • A.S. Weyrich

    Activated platelets signal chemokine synthesis by human monocytes

    J. Clin. Invest.

    (1996)
  • A. Schober

    Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury

    Circulation

    (2002)
  • P.B. Maguire et al.

    Platelet proteomics

    J. Thromb. Haemost.

    (2003)
  • R.P. McEver et al.

    Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment

    J. Clin. Invest.

    (1997)
  • T.S. Mahoney

    Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes

    Proc. Natl. Acad. Sci. U. S. A.

    (2001)
  • T.G. Diacovo

    Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice

    J. Exp. Med.

    (1998)
  • V. Henn

    CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

    Nature

    (1998)
  • V. Henn

    The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40

    Blood

    (2001)
  • B.D. Elzey

    Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments

    Immunity

    (2003)
  • R.D. Stout et al.

    The many roles of CD40 in cell-mediated inflammatory responses

    Immunol. Today

    (1996)
  • S. Russo

    Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial–smooth muscle cell interaction

    J. Immunol.

    (2003)
  • P. Andre

    CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism

    Nat. Med.

    (2002)
  • D.P. Inwald

    CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation

    Circ. Res.

    (2003)
  • Cited by (0)

    View full text